← Back to Clinical Trials
Recruiting NCT06780904

NCT06780904 Comparing Efficacy of Dry Needling Combined with Passive Stretching and Muscle Energy Technique on Myofascial Trigger Points

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06780904
Status Recruiting
Phase
Sponsor University of Peradeniya
Condition Neck Pain
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2024-09-01
Primary Completion 2025-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Dry Needling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2024-09-01 with a primary completion date of 2025-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to assess and compare the efficacy of dry needling (minimally invasive treatment by using a tiny needle) combined with two types of stretching techniques in patients with neck pain for more than 3 months. The main questions it aims to answer are: Which combination of treatment will 1.give faster relief of pain? 2.improve neck range of motion? and 3.improve disability level of a person with neck pain. Participants who are interested will be selected according to eligibility criteria. Participants will be divided into two groups. Initially researcher will assess and interview the participants. Two groups will receive two different combinations of interventions. Pre and post measurements will be obtained and then treatment efficacy will be assessed.

Eligibility Criteria

Inclusion Criteria: * Presence of neck pain for at least 3 months or more * Presence of trigger points in the upper trapezius muscle, either unilaterally or bilaterally * Age between 18 and 60 years Exclusion Criteria: * Having an ongoing infection or fever * Presence of shoulder pathology, such as tendinopathy, impingement syndrome, capsulitis, or bursitis * History of direct trauma to the shoulder or neck * Immunosuppressed individuals (e.g., those with cancer) * Pregnant or recently delivered * Diagnosis of fibromyalgia * History of previous neck or shoulder surgery * Previous local steroid injection or acupuncture * Any abnormality that restricts cervical range of motion (e.g., degenerative changes, cervical spine spondylolisthesis, disc protrusion, extrusion, or sequestration observed in MRI) * Uncontrolled diabetes mellitus * Needle phobia * Metal allergies * Cervical instability * Presence of local skin lesions or infections * Significant cognitive impairment or uncooperative behavior * Participants who have previously undergone any form of physiotherapy intervention for the treatment of neck pain or related conditions

Contact & Investigator

Central Contact

Dissanayake

✉ dilmini008.dd@gmail.com

📞 0702797349

Frequently Asked Questions

Who can join the NCT06780904 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06780904 currently recruiting?

Yes, NCT06780904 is actively recruiting participants. Contact the research team at dilmini008.dd@gmail.com for enrollment information.

Where is the NCT06780904 trial being conducted?

This trial is being conducted at Kandy, Sri Lanka.

Who is sponsoring the NCT06780904 clinical trial?

NCT06780904 is sponsored by University of Peradeniya. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology